3861 results for «2520»
3861 results
New transcatheter mitral valve devices
17 Nov 2025 – From PCR London Valves 2025
This session reviews emerging transcatheter mitral valve devices and their clinical applications. Topics include managing recurrent mitral regurgitation with combined ELASTA-Clip and TMVR approaches, TMVR use in elderly patients, surgical perspectives on device selection, multimodal percutaneous strategies for functional mitral regurgitation, and TMVR as a novel...
TAVI for pure aortic regurgitation: different animal, different challenges, different approaches
17 Nov 2025 – From PCR London Valves 2025
This session delves into the unique anatomical and pathophysiological challenges posed by pure aortic regurgitation and their impact on treatment strategies. It reviews clinical outcomes with established and new transcatheter devices, and presents emerging technologies that promise to advance therapeutic options for this distinct patient population.
Transcatheter mitral valve-in-valve: transcatheter rescue, balloon migration & more
17 Nov 2025 – From PCR London Valves 2025
This session addresses transcatheter mitral valve-in-valve and valve-in-ring interventions in complex clinical contexts. It includes cases of rescue procedures in valvular dysfunction, ECMO-assisted mitral valve-in-ring implantation in severe left ventricular dysfunction, and innovative approaches to mitral ring anatomy challenges, offering practical insights and procedural tips for...
Complex combined interventions - Part 3
17 Nov 2025 – From PCR London Valves 2025
This session highlights complex combined transcatheter interventions, demonstrating simultaneous management of multiple valvular and aortic pathologies. Cases include percutaneous treatment of degenerated bioprosthetic valves, TAVI in rheumatic small annuli with multivalvular disease, and endovascular repair of ascending aortic pseudoaneurysm, illustrating comprehensive strategies for multifaceted cardiovascular disease.
Featured research - TAVI: procedural optimization
17 Nov 2025 – From PCR London Valves 2025
Delve into comprehensive analyses of TAVI procedural outcomes and innovations in this session. Topics include the impact of intercoronary angles on coronary overlap with Evolut valves, mechanisms behind superior outcomes with the latest balloon-expandable valves, and predictive modeling of hemodynamics using physics-enhanced digital twins. Additionally, sex-specific...
TAVI: high coronary risk - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session addresses the challenges and solutions related to high coronary risk in TAVI procedures. Topics include advanced coronary protection strategies, innovative approaches to complex valve-in-valve interventions, the benefits of balloon-assisted techniques, management of right coronary cusp obstruction through UNICORN technology, and prevention of sinus sequestration...
Transcatheter solutions in young and congenital heart disease patients
17 Nov 2025 – From PCR London Valves 2025
This session focuses on transcatheter solutions tailored for young and congenital heart disease patients, featuring challenging edge-to-edge repair in extracardiac Fontan physiology, systemic AV valve TEER in congenital anomalies, multidisciplinary management of repaired tetralogy of Fallot with tricuspid regurgitation, innovative TAVI in young congenital patients, and...
TAVI - Haemodynamic performance and valve durability
18 Nov 2025 – From PCR London Valves 2025
This session provides an in-depth exploration of haemodynamic performance and valve durability following transcatheter aortic valve implantation (TAVI). Attendees will gain a comprehensive understanding of the differences between invasive and echocardiographic gradients post-TAVI, evaluate the haemodynamic profiles of various transcatheter valve platforms, and appreciate their implications...
TAVI: coronary protection
17 Nov 2025 – From PCR London Valves 2025
This session addresses coronary protection strategies during TAVI procedures, especially in complex scenarios such as valve-in-valve interventions, small annulus, and high-risk anatomy. It covers advanced techniques like BASILICA and bioprosthetic valve fracture, providing expert guidance on overcoming challenges to prevent coronary artery obstruction and optimize procedural...
TAVI embolisation - Part 1
18 Nov 2025 – From PCR London Valves 2025
This session explores the critical issue of TAVI valve embolisation, presenting real-world cases that emphasize rapid problem-solving and interventional management strategies. Discussions include bailout techniques for embolised valves, managing multiple valve implantations in severe aortic stenosis, and expectations for TAVI in pure aortic regurgitation. The session...
TAVI: unusual complications - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session reviews unusual and severe complications encountered during TAVI procedures, such as aorto-right ventricular fistula, ventricular perforation, and sinus of Valsalva rupture. It highlights percutaneous treatment successes and endovascular interventions, offering critical insights into managing life-threatening procedural complications effectively.
From GDMT to TEER: management of secondary mitral regurgitation and the timing of transcatheter intervention
18 Nov 2025 – From PCR London Valves 2025
Delve into the comprehensive management of secondary mitral regurgitation, from guideline-directed medical therapy (GDMT) to transcatheter edge-to-edge repair (TEER). This session elucidates the pathophysiology of atrial and ventricular secondary mitral regurgitation, explores optimized heart failure treatments, and reviews the latest evidence on TEER as a therapeutic...
Iatrogenic atrial septum defect closure: a necessary procedure?
18 Nov 2025 – From PCR London Valves 2025
This session addresses the clinical considerations surrounding iatrogenic atrial septal defects (ASDs) resulting from transseptal procedures. It covers prevention of residual defects, diagnostic evaluation, criteria for closure, procedural timing, and management strategies for related complications, supported by illustrative clinical cases demonstrating decision-making nuances.
Unusual structural interventions - Part 2
18 Nov 2025 – From PCR London Valves 2025
This session highlights unusual structural interventions in cardiology, featuring comprehensive CT screening for left atrial appendage closure, management of procedural complications, novel access techniques for balloon aortic valvuloplasty, transcatheter treatment of mitral bioprosthetic valve vegetation, and percutaneous ventricular septal rupture closure success criteria.
TAVI complications - Part 3
18 Nov 2025 – From PCR London Valves 2025
This session provides a detailed examination of TAVI-related complications and their management. Key topics include the STJ-sling technique, valve frame underexpansion diagnosis, real-time intracardiac echocardiography utility, recurrent cardiac arrest scenarios during TAVI, and management strategies for valve in-folding in self-expanding transcatheter valves.
Challenging mitral interventions
18 Nov 2025 – From PCR London Valves 2025
This session explores the complexities of mitral interventions, highlighting advancements and challenges in transcatheter mitral valve repair (TMVR). Topics include the benefits of a simplified single-step TMVR approach, the influence of hemodynamic parameters on MitraClip therapy outcomes, strategies for managing persistent pulmonary oedema, and approaches to...
Mitral TEER masterclass
16 Nov 2025 – From PCR London Valves 2025
This masterclass provides a comprehensive framework for mitral Transcatheter Edge-to-Edge Repair (TEER), covering imaging-guided procedural planning, device selection, and deployment. It emphasizes recognition of anatomical challenges and strategies to avoid and manage complications such as single leaflet device attachment, ensuring optimal outcomes.
Role of PCI in the contemporary management of patients with angina and coronary disease
17 May 2024 – From EuroPCR 2024
This session aims to generate awareness about the distinct phenotypes of coronary artery disease (focal, diffuse, serial) that can be identified through contemporary physiological tools, and the implications of these phenotypes on achieving successful functional PCI results. Participants will also discuss the considerations around using PCI...
Complication occurring during PCI of calcified coronary lesions
17 May 2024 – From EuroPCR 2024
Join this in-depth session on the complications encountered during PCI of calcified coronary lesions, featuring real-world challenges like no flow with coronary dissection, stuck wires, and non-dilatable lesions. From the "Kokeshi phenomenon" to IVL-induced RCA dissection, this session highlights key lessons and red flags, emphasizing the...
EuroPCR 2024 Closing Ceremony
17 May 2024 – From EuroPCR 2024
This session is the closing ceremony for EuroPCR 2024. It includes the presentation of the PCR's Got Talent competition, a discussion on the new developments in PCI such as angiography-based computational physiology, AI, and vulnerable plaque intervention, as well as highlights from the congress. The ceremony...
